Sotabase

Career

· Vice President, Global Food Services, Delivery Hero2021–
· Founder and Managing Director, Spice Trails Ventures Private Limited2021–
· India Head, KitchenPlus India2020–2021
· COO- Swiggy Access and New Supply Initiatives, Swiggy2017–2020
· Founder, 48East2016–2017
· CEO, Papa Johns Corporate Office2014–2016
· CEO, GFA Global (Global Franchise Architects)2005–2016
· Franchise Manager, Middle East, Thomasklien Intl., Dubai2004–2005
· Training Consultant, McDonald's1998–2004

Publications (146)

Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
JACC Cardiovascular Imaging · 2012
155
cited
Anti-Tumor Necrosis Factor-&agr; Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Circulation · 2012
147
cited
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.
British Journal of Clinical Pharmacology · 2016
144
cited
Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
HYPERTENSION · 2015
140
cited
Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure
Journal of Hypertension · 2013
129
cited
Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial
PLoS ONE · 2014
117
cited
Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
American Journal of Cardiovascular Drugs · 2019
111
cited
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial
BMJ Open · 2018
100
cited
Aldehyde Dehydrogenase 2 Plays a Role in the Bioactivation of Nitroglycerin in Humans
Arteriosclerosis, Thrombosis and Vascular Biology · 2005
98
cited
Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide–Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia
Circulation · 2011
98
cited
Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
American Journal of Cardiovascular Drugs · 2014
84
cited
The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform
Journal of Hypertension · 2009
77
cited
Niclosamide—A promising treatment for COVID‐19
British Journal of Pharmacology · 2021
67
cited
The role of epoxyeicosatrienoic acids in the cardiovascular system
British Journal of Clinical Pharmacology · 2015
66
cited
Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction.
International Journal of Cardiology · 2008
63
cited
Quantification of Lung PET Images: Challenges and Opportunities
Journal of Nuclear Medicine · 2017
63
cited
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
Chest · 2017
62
cited
[Pyr1]Apelin-13(1–12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13
Frontiers in Neuroscience · 2017
50
cited
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.
NEJM Evidence · 2021
47
cited
The Role of the Autonomic Nervous System in the Regulation of Aortic Stiffness
HYPERTENSION · 2016
46
cited
Sotabase
Joseph Cheriyan | Researcher Profile | Sotabase | Sotabase